Monday, January 08, 2007

Open Thread - Monday

NPR related comments welcomed.


Anonymous said...

Just why is Inskeep spending so much time challenging Sharod Brown on his stance regarding Free Trade this morning?

What percentage of Americans want to (or focus on the issue of) expanding Free Trade policies at this point? Whose point of view is he arguing? Is it that of his listeners?

And ... ah yes, democrats have to be careful not to be on the "losing side of history" with regard to free trade. Thanks for the "analysis" Cokie. You are, as every Monday morning, just loathsome.

Anonymous said...

While I agree with you, at least that piece had relevant news. I tried to listen to NPR twice this morning after I got up. First time I was treated to a hot cocoa story, so I flipped off the readio. Tried again later and they were interviewing some 2-year-old ktrained monkey about sports.

Anonymous said...

Yes, Stupid Monkey Preznit is about to open up the Gates of Hell, and we get the...Hot Cocoa story! Jeebus.

Anonymous said...

NPR does seem to run too many feature stories. I'm sure that's what the focus groups say they should do. "Nero Phiddles Radio." Oooo, bad poetic license.

David Green said...


NPR: Wrong History

The horror, the horror! I just heard Cokie Roberts, National Public Radio's political analyst, tell listeners that the Democrats would suffer if they oppose President Bush's trade agenda, because they would be "on the wrong side of history."

It would be great to be able to know the future course of history, but I question whether Ms. Roberts really has such knowledge. Has she looked into the out years of the 21st century and determined that the copyright and patent protection will become ever more stringent? Will the heirs of the Clinton-Bush trade agenda have our homes, offices, and public places thoroughly wired so that anyone using an unauthorized reproduction of copyrighted can be immediately apprehended and prosecuted? Will they have bathtub labs carefully policed so that anyone attempting to manufacture lifesaving drugs that are subject to patent protection will be harshly prosecuted for interferring with Pfizer and Merck's profits?

That may be what the future holds, but I would like to think that it is still contested, not predetermined, as Ms. Roberts claims. Of course, those opposing this future would have a better chance if they didn't have to pay taxes so that "experts" like Ms. Roberts could tell the public that they have no chance.

--Dean Baker